Abstract The current report describes a case of a primary cardiac lymphoma. For early and appropriate treatment of a cardiac mass it is not only important to determine its localization and extension but also to differentiate between malignant and benign lesions. This report demonstrates that not only transthoracic echocardiography but also the other different forms of echocardiography such as transesophageal echocardiography, as well as contrast and intracardiac echocardiography, are useful tools in the diagnostic workup of cardiac masses.
A 48-year-old man was referred to our hospital for further diagnostic evaluation of a right cardiac process discovered at a transabdominal ultrasound study performed in the referring hospital. The patient had a 3 weeks history of recurrent fever (up to 40 C), night sweat and weight loss (9 kg in 3 weeks). Except for general discomfort, the patient had no cardiac complaints.
On physical examination there was a regular and equal pulse of 88 beats per minute with a blood pressure of 110/70 mmHg. Central venous pressure was normal. Auscultation of the heart and lungs revealed no abnormalities. Although the right upper abdomen was slightly tender, the liver was not enlarged. No lymphadenopathy was present.
Laboratory analysis showed minimal abnormalities: an elevated ESR (120 mm/h), a slight normocytic anemia (hemoglobin concentration 7.0 mmol/ L) and an elevated lactate dehydrogenase (748 U/ L; normal !450 U/L). Chest X-ray was normal. The ECG showed a prolonged PR interval of 220 ms as the only abnormality.
Abdominal ultrasound did not show abnormalities in the abdominal cavity, but a solid, irregular thickening of the free wall of the right ventricle and right atrium and some pericardial effusion was noted.
Subsequently, transthoracic echocardiography (TTE) demonstrated a thickened free wall of the right ventricle with a lobulated, large, enhancing epicardial mass invading the right atrium and extending around the aortic root. There was also global pericardial effusion ( Fig. 1A and B) .
Contrast echocardiography was performed by intravenously administrating SonoVue Ò (Bracco Inc. Diagnostics; sulphur hexafluoride 8 mL/mL) with a single or two injections of 2e3 mL in the maximum dose of 5 mL per examination (Vivid 7 scanner 1.7 MHz, power Z mechanical index 0.07). Contrast perfusion imaging showed partial perfusion of the cardiac mass ( Fig. 1C and D) . Transesophageal echocardiography (TEE) confirmed a large mass invading the right atrium and the free wall of the right ventricle, which extended to the aortic root. Multislice computed tomography (MSCT) of the thorax and abdomen confirmed the echocardiographic findings and ruled out lymphadenopathy and other masses (Fig. 2) . A primary cardiac neoplastic process was suspected. With combined intracardiac echocardiography and fluoroscopic guidance, percutaneous intracardiac biopsy of the right atrium and right ventricle was performed (Fig. 3A) . 5 Subsequent histopathological examination revealed the presence of a blastic lymphoid infiltrative tumor that was CD45, CD20 and BCL6 positive. Immunocytology suggested an intermediate/high grade B-cell non-Hodgkin lymphoma, most probably diffuse large-B-cell lymphoma. In situ hybridization Chemotherapy treatment consisting of doxorubicin, vincristine, cyclophosphamide and prednisone was initiated. During the first course of chemotherapy the atrioventricular conduction worsened with a prolonged PR interval and finally, the ECG showed a third degree atrioventricular block. Due to the absence of hemodynamic consequences, management was conservative.
After 3 months of treatment with chemotherapy the symptoms resolved and follow-up TTE showed an almost complete resolution of the cardiac mass (Fig. 3 BeD) . The atrioventricular block resolved completely.
Discussion
Lymphoma is the second most common tumor involving the heart in patients with the acquired immunodeficiency syndrome (AIDS).
1 Cardiac involvement with non-Hodgkin lymphoma usually reflects systemic dissemination of the disease. Non-Hodgkin lymphomas in patients with AIDS usually derive from B-cells and are typically high grade and disseminated. However, even in AIDS patients, primary cardiac lymphoma is extremely rare. 2e4 The lymphoma typically involves the right atrium and involvement of other chambers is less common. 3, 6 Most patients have no complaints or non-specific symptoms, but they can also present with pericardial effusion, heart failure and arrhythmias. 2e4,7 Two-dimensional echocardiography is considered the most sensitive imaging modality for the evaluation of cardiac masses. 7, 8 Although a tissue diagnosis is still required, early differentiation between malignant and benign cardiac masses is important for early and appropriate treatment. Kirkpatrick et al. recently demonstrated the use of echocardiographic contrast perfusion imaging in differentiating the neo-vascularization of malignancies from the avascularity of thrombi or sparse vascularity of stromal tumors. 9 The authors concluded that malignant and vascular tumors compared with adjacent myocardium showed hyperenhancement following contrast administration. 9 In the current patient, echocardiographic contrast perfusion imaging also showed hyper-enhancement of the tumor compared to adjacent myocardium, highly suspicious for malignancy. Subsequent TEE confirmed the extension of the tumor. Next myocardial biopsy was taken under the guidance of intracardiac echocardiography that allowed appropriate positioning of the biopsy catheter. 5 Follow-up TTE during chemotherapy treatment showed a significant reduction of the tumor mass.
This report provides an example of how different forms of echocardiography (TTE, TEE, contrast echocardiography, intracardiac echocardiography) can be used to assist in a comprehensive evaluation of cardiac masses.
Conclusion
Different echocardiographic techniques have been demonstrated to be useful in comprehensive evaluation of cardiac masses. In particular, contrast echocardiography to assess perfusion is a useful technique to further evaluate cardiac tumors. Early differentiation is important for further diagnosis, treatment and prognosis. Intracardiac echocardiography on the other hand, may be useful in guiding tissue biopsy.
